You have free access to this content

Cytometry Part B: Clinical Cytometry

Cover image for Vol. 82B Issue 3

May 2012

Volume 82B, Issue 3

Pages v–vi, 123–191

  1. Issue Highlights

    1. Top of page
    2. Issue Highlights
    3. Original Articles
    4. Brief Communications
    5. Case Study Interpretations - Portland: Introduction
    6. Case Study Interpretations - Portland: Case 1
    7. Case Study Interpretations - Portland: Case 2
    8. Case Study Interpretations - Portland: Case 3
    9. Case Study Interpretations - Portland: Case 4
    1. You have free access to this content
      Issue Highlights—May 2012 (pages v–vi)

      Frederic Preffer and Francesco Lanza

      Article first published online: 18 APR 2012 | DOI: 10.1002/cyto.b.21025

  2. Original Articles

    1. Top of page
    2. Issue Highlights
    3. Original Articles
    4. Brief Communications
    5. Case Study Interpretations - Portland: Introduction
    6. Case Study Interpretations - Portland: Case 1
    7. Case Study Interpretations - Portland: Case 2
    8. Case Study Interpretations - Portland: Case 3
    9. Case Study Interpretations - Portland: Case 4
    1. You have free access to this content
      Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia (pages 123–131)

      Marianne Hutchings Hoffmann, Tobias Wirenfeldt Klausen, Martin Boegsted, Steffen Falgreen Larsen, Alexander Schmitz, Eva Birgitte Leinoe, Kjeld Schmiegelow, Henrik Hasle, Olav Jonas Bergmann, Suzette Sorensen, Mette Nyegaard, Karen Dybkær and Hans Erik Johnsen

      Article first published online: 10 FEB 2012 | DOI: 10.1002/cyto.b.20633

    2. You have free access to this content
      CD300a is expressed on human basophils and seems to inhibit IgE/FcεRI-dependent anaphylactic degranulation (pages 132–138)

      Vito Sabato, Marjoke M. Verweij, Chris H. Bridts, Francesca Levi-Schaffer, Bernhard F. Gibbs, Luc S. De Clerck, Domenico Schiavino and Didier G. Ebo

      Article first published online: 15 DEC 2011 | DOI: 10.1002/cyto.b.21003

    3. You have free access to this content
    4. You have free access to this content
      Frequency and prognostic impact of the aberrant CD8 expression in 5,523 patients with chronic lymphocytic leukemia (pages 145–150)

      Wolfgang Kern, Ulrike Bacher, Claudia Haferlach, Tamara Alpermann, Frank Dicker, Susanne Schnittger and Torsten Haferlach

      Article first published online: 5 DEC 2011 | DOI: 10.1002/cyto.b.21002

    5. You have free access to this content
      Assay validation of phosphorylated S6 ribosomal protein for a pharmacodynamic monitoring of mTOR-inhibitors in peripheral human blood (pages 151–157)

      Maja-Theresa Dieterlen, Hartmuth B. Bittner, Sara Klein, Sandy von Salisch, Anja Mittag, Attila Tárnok, Stefan Dhein, Friedrich W. Mohr and Markus J. Barten

      Article first published online: 23 DEC 2011 | DOI: 10.1002/cyto.b.21005

    6. You have free access to this content
      Functional pathway analysis in acute myeloid leukemia using single cell network profiling assay: Effect of specimen source (bone marrow or peripheral blood) on assay readouts (pages 158–172)

      Alessandra Cesano, David B. Rosen, Pat O'Meara, Santosh Putta, Urte Gayko, David C. Spellmeyer, Larry D. Cripe, Zhuoxin Sun, Hajime Uno, Mark R. Litzow, Martin S. Tallman and Elisabeth Paietta

      Article first published online: 14 FEB 2012 | DOI: 10.1002/cyto.b.21007

  3. Brief Communications

    1. Top of page
    2. Issue Highlights
    3. Original Articles
    4. Brief Communications
    5. Case Study Interpretations - Portland: Introduction
    6. Case Study Interpretations - Portland: Case 1
    7. Case Study Interpretations - Portland: Case 2
    8. Case Study Interpretations - Portland: Case 3
    9. Case Study Interpretations - Portland: Case 4
    1. You have free access to this content
  4. Case Study Interpretations - Portland: Introduction

    1. Top of page
    2. Issue Highlights
    3. Original Articles
    4. Brief Communications
    5. Case Study Interpretations - Portland: Introduction
    6. Case Study Interpretations - Portland: Case 1
    7. Case Study Interpretations - Portland: Case 2
    8. Case Study Interpretations - Portland: Case 3
    9. Case Study Interpretations - Portland: Case 4
    1. You have free access to this content
  5. Case Study Interpretations - Portland: Case 1

    1. Top of page
    2. Issue Highlights
    3. Original Articles
    4. Brief Communications
    5. Case Study Interpretations - Portland: Introduction
    6. Case Study Interpretations - Portland: Case 1
    7. Case Study Interpretations - Portland: Case 2
    8. Case Study Interpretations - Portland: Case 3
    9. Case Study Interpretations - Portland: Case 4
    1. You have free access to this content
      Case study interpretation—Portland: Case 1 (pages 177–179)

      Prashant Tembhare, Constance M. Yuan, Liqiang Xi, Gerald Marti, Mark Raffeld and Maryalice Stetler-Stevenson

      Article first published online: 19 MAR 2012 | DOI: 10.1002/cyto.b.21012

  6. Case Study Interpretations - Portland: Case 2

    1. Top of page
    2. Issue Highlights
    3. Original Articles
    4. Brief Communications
    5. Case Study Interpretations - Portland: Introduction
    6. Case Study Interpretations - Portland: Case 1
    7. Case Study Interpretations - Portland: Case 2
    8. Case Study Interpretations - Portland: Case 3
    9. Case Study Interpretations - Portland: Case 4
    1. You have free access to this content
  7. Case Study Interpretations - Portland: Case 3

    1. Top of page
    2. Issue Highlights
    3. Original Articles
    4. Brief Communications
    5. Case Study Interpretations - Portland: Introduction
    6. Case Study Interpretations - Portland: Case 1
    7. Case Study Interpretations - Portland: Case 2
    8. Case Study Interpretations - Portland: Case 3
    9. Case Study Interpretations - Portland: Case 4
    1. You have free access to this content
  8. Case Study Interpretations - Portland: Case 4

    1. Top of page
    2. Issue Highlights
    3. Original Articles
    4. Brief Communications
    5. Case Study Interpretations - Portland: Introduction
    6. Case Study Interpretations - Portland: Case 1
    7. Case Study Interpretations - Portland: Case 2
    8. Case Study Interpretations - Portland: Case 3
    9. Case Study Interpretations - Portland: Case 4
    1. You have free access to this content

SEARCH

SEARCH BY CITATION